329 Early blood cell count test (BCT) for survival prediction for non-small cell lung cancer patients treated with atezolizumab: integrated analysis of 4 multicenter clinical trials

Zhou, J.-G., Wong, A. H.-H., Wang, H., Jin, S.-H., Tan, F., Chen, Y.-Z., … Gaipl, U. (2021). 329 Early blood cell count test (BCT) for survival prediction for non-small cell lung cancer patients treated with atezolizumab: integrated analysis of 4 multicenter clinical trials (pp. A355–A355). BMJ. https://doi.org/10.1136/jitc-2021-sitc2021.329